Scientists test cancer drug safety in people with liver damage
NCT ID NCT07144111
Summary
This early study aims to understand how liver problems affect how the body processes a single dose of the cancer drug inavolisib. It will compare drug levels and safety in 32 adults with moderate or severe liver impairment to healthy adults with normal liver function. The goal is to gather information to help guide future safe use of the drug in patients with liver issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orange County Research Center
RECRUITINGLake Forest, California, 92630, United States
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
-
Pinnacle Clinical Research - San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
The Texas Liver Institute, Inc.
RECRUITINGSan Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.